Steve Kalloger Steve Kalloger

Evidence Brief November 06, 2026

This week’s Evidence Brief examines whether simpler digital interventions can deliver greater value, how biology and competing mortality can inform treatment de-escalation, and whether experiencing a treatment changes how patients value it. Together, the studies challenge the assumption that one estimate of value or preference applies across contexts.

Read More
Steve Kalloger Steve Kalloger

Evidence Brief October 30, 2026

This week’s Evidence Brief examines three conditions required for decision-grade evidence: analytical reliability, an appropriate balance between incremental benefit and burden, and successful implementation. New studies show why errors upstream of analysis, treatment intensification, information design, and clinical behavior can all alter the eventual decision.

Read More
Steve Kalloger Steve Kalloger

Evidence Brief October 23, 2026

This week’s Evidence Brief examines how modeling assumptions, treatment timing, and real-world implementation can change apparently straightforward conclusions. New oncology studies show why cost-effectiveness, comparative effectiveness, and decision frameworks need to be evaluated under the conditions in which they will actually be used.

Read More
Steve Kalloger Steve Kalloger

Evidence Brief October 16, 2026

This week’s Evidence Brief examines how uncertainty changes treatment preferences, how patient-reported outcomes reveal benefits missed by conventional endpoints, and why economic value changes as intervention complexity and drug prices change. Decision-relevant evidence depends on matching assumptions, outcomes, and context to the decision being made.

Read More
Steve Kalloger Steve Kalloger

Evidence Brief October 9, 2026

This week’s Evidence Brief examines how treatment burden is measured, why physicians and practices influence who enters oncology trials, and what happens when reimbursement precedes confirmation of clinical benefit. The common lesson: evidence credibility depends on what is measured, who is represented, and how uncertainty is managed.

Read More
Steve Kalloger Steve Kalloger

Evidence Brief October 2, 2026

This week’s Evidence Brief examines how the structure of a decision problem shapes the evidence it can produce. New work in CLL patient preferences, target-trial emulation, and Medicare oncology pricing shows why attribute definition, causal design, and lifecycle value strategy need to be specified before the analysis begins

Read More
Steve Kalloger Steve Kalloger

Evidence Brief September 25, 2026

This week’s Evidence Brief examines what happens when evidence generation changes the decision environment itself. New studies show how genomic information can alter treatment preferences, electronic PROs can become part of the intervention, and real-world evidence quality depends on decisions made long before statistical analysis begins.

Read More
Steve Kalloger Steve Kalloger

Evidence Brief September 18, 2026

This week’s Evidence Brief examines why agreement on what matters does not necessarily mean agreement on how much it matters. New oncology preference studies highlight important differences between patient, caregiver, clinician, and public perspectives, while new economic evidence shows how expanding the analysis from an isolated technology to the broader care pathway can materially change the value proposition.

Read More
Steve Kalloger Steve Kalloger

Evidence Brief September 11, 2026

New work on response shift, shared decision-making, threshold pricing, and Medicare value assessment underscores a common theme: clinical outcomes, patient preferences, and economic value are all shaped by the context in which they are measured and used.

Read More
Steve Kalloger Steve Kalloger

Evidence Brief September 4, 2026

From cancer-care delivery models to side-effect framing and treatment-timing definitions, this week’s evidence highlights how study design choices made upstream of analysis can materially influence quantitative results and their interpretation.

Read More
Steve Kalloger Steve Kalloger

Evidence Brief August 28, 2026

How survival extrapolation, DCE design, decision burden, and changing clinical context can shape the evidence we observe. This week’s brief looks at why measured choices are not always the same thing as underlying preferences.

Read More

Start with a focused discussion

Tell us about the decision, evidence gap, or research problem you are facing. Initial consultations are used to clarify the problem, determine fit, and identify the most useful next step.